Home › Funds › Pacer Advisors, Inc. › GILD

Pacer Advisors, Inc. position in GILD

GILEAD SCIENCES INC · Health Care

Pacer Advisors, Inc. reported holding 3,110,000 shares of GILD (GILEAD SCIENCES INC) in its Q2 2026 13F filing — a position valued at US$392.9M, representing 1.12% of its reported portfolio and ranking #11 among its reported holdings. Pacer Advisors, Inc. has disclosed GILD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)3.11M sh
Reported value held$392.92M
Portfolio Weight1.12%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Pacer Advisors, Inc.'s GILD position evolved

Pacer Advisors, Inc. first disclosed a stake in GILD in Q3 2023 at 4,552,732 shares (US$341.2M). The position peaked in Q4 2024 at 6,434,665 shares, worth US$594.4M. Across 12 filings, Pacer Advisors, Inc. increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 3,110,000 shares valued at US$392.9M — an increase of 164,758 shares quarter over quarter.. Notable position changes include a 25% increase in Q1 2024 (shares fell 6% over the following quarter), a 90% trim in Q3 2024 (shares rose 11% over the following quarter), a 723% increase in Q4 2024 (shares rose 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.55M $341.18M New
Q4 2023 5.05M $408.83M Add
Q1 2024 6.32M $463.30M Add
Q2 2024 7.89M $541.31M Add
Q3 2024 781.59K $65.53M Reduce
Q4 2024 6.43M $594.37M Add
Q1 2025 4.89M $547.38M Reduce
Q2 2025 4.12M $456.75M Reduce
Q3 2025 3.59M $398.57M Reduce
Q4 2025 3.38M $415.08M Reduce
Q1 2026 2.95M $410.48M Reduce
Q2 2026 3.11M $392.92M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Pacer Advisors, Inc. held GILD?

Pacer Advisors, Inc. has disclosed GILD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Pacer Advisors, Inc.'s current position in GILD?

As of Q2 2026, Pacer Advisors, Inc. holds 3.11M shares of GILD (GILEAD SCIENCES INC), valued at $392.92M, representing 1.12% of its reported portfolio and ranking #11.

Has Pacer Advisors, Inc. been buying or selling GILD?

In the latest 13F filing (Q2 2026), Pacer Advisors, Inc. increased its position in GILD. The position peaked in Q4 2024 at 6.43M shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.